Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Debt (2019 - 2022)

Historic Non-Current Debt for Korro Bio (KRRO) over the last 4 years, with Q4 2022 value amounting to $4.2 million.

  • Korro Bio's Non-Current Debt fell 7058.66% to $4.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.2 million, marking a year-over-year decrease of 7058.66%. This contributed to the annual value of $4.2 million for FY2022, which is 7058.66% down from last year.
  • As of Q4 2022, Korro Bio's Non-Current Debt stood at $4.2 million, which was down 7058.66% from $6.7 million recorded in Q3 2022.
  • Korro Bio's 5-year Non-Current Debt high stood at $15.0 million for Q4 2020, and its period low was $180000.0 during Q4 2019.
  • Moreover, its 4-year median value for Non-Current Debt was $11.7 million (2022), whereas its average is $9.7 million.
  • As far as peak fluctuations go, Korro Bio's Non-Current Debt skyrocketed by 823333.33% in 2020, and later plummeted by 7058.66% in 2022.
  • Quarter analysis of 4 years shows Korro Bio's Non-Current Debt stood at $180000.0 in 2019, then surged by 8233.33% to $15.0 million in 2020, then decreased by 5.55% to $14.2 million in 2021, then crashed by 70.59% to $4.2 million in 2022.
  • Its Non-Current Debt stands at $4.2 million for Q4 2022, versus $6.7 million for Q3 2022 and $9.2 million for Q2 2022.